Dr. Rockson's Acebilustat news
A few days ago the scientific article on Phase 2 was published, confirming that "Selective leukotriene B4 antagonism is associated with improvement in overall objective and subjective measures of lymphedema. This study provides the first evidence in support of acebilustat as a novel oral therapeutic for chronic lymphedema".
No news on Phase 3 but I guess that's gonna take a bit longer. Hopefully Dr Rockson, now that the article was published, will discuss soon the results on the LEARN YouTube channel.